Tarsons ProductsNSE:TARSONS +1.11%83 ROA % is 1.41% as of Mar. 2026, which is 91% below its 10-year median of 15.16. GuruFocus rates NSE:TARSONS with a GF Score™ of 83/100 and a GF Value™ of ₹565.17 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 856 Medical Devices & Instruments companies, Tarsons Products ranks better than 52.92% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Tarsons Products's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹167 Mil.
Tarsons Products's average Total Assets over the quarter that ended in Mar. 2026 was ₹11,858 Mil. Therefore, Tarsons Products's annualized ROA % for the quarter that ended in Mar. 2026 was 1.41%.
The historical rank and industry rank for Tarsons Products's ROA % or its related term are showing as below:
NSE:TARSONS'
s ROA % Range Over the Past 10 Years
Min: 1.25 Med: 15.16 Max: 25.29
Current: 1.25
During the past 8 years, Tarsons Products's highest ROA % was 25.29%. The lowest was 1.25%. And the median was 15.16%.
NSE:TARSONS's ROA % is ranked better than 52.92% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.545
vs NSE:TARSONS: 1.25
Tarsons Products (NSE:TARSONS) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Tarsons Products ROA % Related Terms
Tarsons Products ROA % Historical Data
* Premium members only.
The historical data trend for Tarsons Products's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Tarsons Products's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tarsons Products ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tarsons Products's ROA % distribution charts can be found below:
* The bar in red indicates where Tarsons Products's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Tarsons Products (NSE:TARSONS) has a ROA % of 1.41% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tarsons Products and its competitors. This is 91% below median its historical median of 15.16. Over the past decade, Tarsons Products' ROA % has ranged from 1.25 to 25.29. According to the industry distribution chart, Tarsons Products ranks #403 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 47.1%.
Is Tarsons Products' ROA % too high?
Tarsons Products' current ROA % of 1.41% is 91% below median its 10-year median of 15.16. Over the past 10 years, this metric has ranged from a low of 1.25 to a high of 25.29. The Medical Devices & Instruments industry median ROA % is 0.55. Tarsons Products' value of 1.41% is 158.7% above this industry median. Based on the distribution chart, Tarsons Products ranks #403 out of 856 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Tarsons Products has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tarsons Products' ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Tarsons Products ranks #403 out of 856 companies for ROA %. This puts Tarsons Products in the upper half of its industry. The industry median ROA % is 0.55. Tarsons Products' value of 1.41% is 158.7% above this benchmark. Historically, Tarsons Products' own ROA % has ranged from 1.25 to 25.29 over the past decade. While the company's 10-year median is 15.16 vs. the industry median of 0.55, Tarsons Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tarsons Products's current ROA % of 1.41% is 158.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Tarsons Products and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tarsons Products's current ROA % is 1.41%, which is 91% below median its own 10-year median of 15.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tarsons Products stock overvalued right now?
Based on GuruFocus' analysis, Tarsons Products (NSE:TARSONS) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹565.17, compared to a current price of ₹296.40 — trading 47.6% below its estimated fair value. The current ROA % is 1.41%, which is 91% below median its 10-year median of 15.16 and 158.7% above the Medical Devices & Instruments industry median of 0.55. Tarsons Products' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Tarsons Products (NSE:TARSONS), the current ROA % is 1.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tarsons Products (NSE:TARSONS) Overvalued in 2026?
Based on GuruFocus' analysis, Tarsons Products stock appears to be undervalued.
The current stock price of ₹296.40 is trading 47.6% below its estimated GF Value™ of ₹565.17.
GuruFocus considers Tarsons Products to be Significantly Undervalued.
Key valuation signals for NSE:TARSONS:
ROA %: 1.41% (91% below median its 10-year median of 15.16)
GF Value™: ₹565.17 vs. price of ₹296.40 (47.6% below fair value)
Industry Position: 158.7% above the Medical Devices & Instruments median (#403 of 856)
No single metric tells the full story. See the NSE:TARSONS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tarsons Products Ltd is an Indian labware Company engaged in designing, developing, manufacturing, and marketing consumables, reusables, and other including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies, and hospitals. The Company is also engaged in the manufacturing of a wide range of quality labware products that help scientific discovery and improve healthcare. The company generates the majority of its revenue from the sale of manufactured plastic products. Geographically, the company generates the majority of its revenue from India.
83GF Score
Get the complete analysis for NSE:TARSONS
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TARSONS has been successfully added to your 
